L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia

Stopped early · Phase 2

Conditions studied: Pre-Eclampsia

In brief

This study is intended to assess the efficacy of L-arginine supplementation with antioxidant vitamins delivered in a medical food in reducing the incidence of preeclampsia in a high-risk population.

Key facts

Study ID

NCT00469846

Run by

Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes

People needed

585

Starts

2001-01-01

Expected to finish

2006-11-01

Last updated by the study team

2007-05-08

Who can join

Age: 19 and older, up to 32. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Previous pregnancy complicated with pre-eclampsia/eclampsia
• Singleton pregnancy
• Gestational age >20 weeks <34 weeks
• Protein excretion < 300 mg/day

You may not qualify if…

• Multiple gestation
• Major fetal anomaly
• Pre-existing hypertension
• Pre-existing renal disease
• Diabetes
• Collagen vascular disease
• Cancer or strong family history of cancer in first degree relatives
• Preexisting maternal disease requiring medication

Where it is running

• Univesity of Pennsylvania — Philadelphia, Pennsylvania, United States
• Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes — Mexico City, D.F., Mexico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.